Cargando…

Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus

Type 1 diabetes mellitus (T1DM) is associated with low bone mass and a higher risk for fractures. Dickkopf-1 (Dkk1), which inhibits Wnt signaling, osteoblast function, and bone formation, has been found to be increased in the serum of patients with T1DM. Here, we investigated the functional role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hildebrandt, Nick, Colditz, Juliane, Dutra, Caio, Goes, Paula, Salbach-Hirsch, Juliane, Thiele, Sylvia, Hofbauer, Lorenz C., Rauner, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820472/
https://www.ncbi.nlm.nih.gov/pubmed/33479403
http://dx.doi.org/10.1038/s41598-021-81543-7
_version_ 1783639221381103616
author Hildebrandt, Nick
Colditz, Juliane
Dutra, Caio
Goes, Paula
Salbach-Hirsch, Juliane
Thiele, Sylvia
Hofbauer, Lorenz C.
Rauner, Martina
author_facet Hildebrandt, Nick
Colditz, Juliane
Dutra, Caio
Goes, Paula
Salbach-Hirsch, Juliane
Thiele, Sylvia
Hofbauer, Lorenz C.
Rauner, Martina
author_sort Hildebrandt, Nick
collection PubMed
description Type 1 diabetes mellitus (T1DM) is associated with low bone mass and a higher risk for fractures. Dickkopf-1 (Dkk1), which inhibits Wnt signaling, osteoblast function, and bone formation, has been found to be increased in the serum of patients with T1DM. Here, we investigated the functional role of Dkk1 in T1DM-induced bone loss in mice. T1DM was induced in 10-week-old male mice with Dkk1-deficiency in late osteoblasts/osteocytes (Dkk1(f/f);Dmp1-Cre, cKO) and littermate control mice by 5 subsequent injections of streptozotocin (40 mg/kg). Age-matched, non-diabetic control groups received citrate buffer instead. At week 12, calvarial defects were created in subgroups of each cohort. After a total of 16 weeks, weight, fat, the femoral bone phenotype and the area of the bone defect were analyzed using µCT and dynamic histomorphometry. During the experiment, diabetic WT and cKO mice did not gain body weight compared to control mice. Further they lost their perigonadal and subcutaneous fat pads. Diabetic mice had highly elevated serum glucose levels and impaired glucose tolerance, regardless of their Dkk1 levels. T1DM led to a 36% decrease in trabecular bone volume in Cre− negative control animals, whereas Dkk1 cKO mice only lost 16%. Of note, Dkk1 cKO mice were completely protected from T1DM-induced cortical bone loss. T1DM suppressed the bone formation rate, the number of osteoblasts at trabecular bone, serum levels of P1NP and bone defect healing in both, Dkk1-deficient and sufficient, mice. This may be explained by increased serum sclerostin levels in both genotypes and the strict dependence on bone formation for bone defect healing. In contrast, the number of osteoclasts and TRACP 5b serum levels only increased in diabetic control mice, but not in Dkk1 cKO mice. In summary, Dkk1 derived from osteogenic cells does not influence the development of T1DM but plays a crucial role in T1DM-induced bone loss in male mice by regulating osteoclast numbers.
format Online
Article
Text
id pubmed-7820472
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78204722021-01-26 Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus Hildebrandt, Nick Colditz, Juliane Dutra, Caio Goes, Paula Salbach-Hirsch, Juliane Thiele, Sylvia Hofbauer, Lorenz C. Rauner, Martina Sci Rep Article Type 1 diabetes mellitus (T1DM) is associated with low bone mass and a higher risk for fractures. Dickkopf-1 (Dkk1), which inhibits Wnt signaling, osteoblast function, and bone formation, has been found to be increased in the serum of patients with T1DM. Here, we investigated the functional role of Dkk1 in T1DM-induced bone loss in mice. T1DM was induced in 10-week-old male mice with Dkk1-deficiency in late osteoblasts/osteocytes (Dkk1(f/f);Dmp1-Cre, cKO) and littermate control mice by 5 subsequent injections of streptozotocin (40 mg/kg). Age-matched, non-diabetic control groups received citrate buffer instead. At week 12, calvarial defects were created in subgroups of each cohort. After a total of 16 weeks, weight, fat, the femoral bone phenotype and the area of the bone defect were analyzed using µCT and dynamic histomorphometry. During the experiment, diabetic WT and cKO mice did not gain body weight compared to control mice. Further they lost their perigonadal and subcutaneous fat pads. Diabetic mice had highly elevated serum glucose levels and impaired glucose tolerance, regardless of their Dkk1 levels. T1DM led to a 36% decrease in trabecular bone volume in Cre− negative control animals, whereas Dkk1 cKO mice only lost 16%. Of note, Dkk1 cKO mice were completely protected from T1DM-induced cortical bone loss. T1DM suppressed the bone formation rate, the number of osteoblasts at trabecular bone, serum levels of P1NP and bone defect healing in both, Dkk1-deficient and sufficient, mice. This may be explained by increased serum sclerostin levels in both genotypes and the strict dependence on bone formation for bone defect healing. In contrast, the number of osteoclasts and TRACP 5b serum levels only increased in diabetic control mice, but not in Dkk1 cKO mice. In summary, Dkk1 derived from osteogenic cells does not influence the development of T1DM but plays a crucial role in T1DM-induced bone loss in male mice by regulating osteoclast numbers. Nature Publishing Group UK 2021-01-21 /pmc/articles/PMC7820472/ /pubmed/33479403 http://dx.doi.org/10.1038/s41598-021-81543-7 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Hildebrandt, Nick
Colditz, Juliane
Dutra, Caio
Goes, Paula
Salbach-Hirsch, Juliane
Thiele, Sylvia
Hofbauer, Lorenz C.
Rauner, Martina
Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus
title Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus
title_full Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus
title_fullStr Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus
title_full_unstemmed Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus
title_short Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus
title_sort role of osteogenic dickkopf-1 in bone remodeling and bone healing in mice with type i diabetes mellitus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820472/
https://www.ncbi.nlm.nih.gov/pubmed/33479403
http://dx.doi.org/10.1038/s41598-021-81543-7
work_keys_str_mv AT hildebrandtnick roleofosteogenicdickkopf1inboneremodelingandbonehealinginmicewithtypeidiabetesmellitus
AT colditzjuliane roleofosteogenicdickkopf1inboneremodelingandbonehealinginmicewithtypeidiabetesmellitus
AT dutracaio roleofosteogenicdickkopf1inboneremodelingandbonehealinginmicewithtypeidiabetesmellitus
AT goespaula roleofosteogenicdickkopf1inboneremodelingandbonehealinginmicewithtypeidiabetesmellitus
AT salbachhirschjuliane roleofosteogenicdickkopf1inboneremodelingandbonehealinginmicewithtypeidiabetesmellitus
AT thielesylvia roleofosteogenicdickkopf1inboneremodelingandbonehealinginmicewithtypeidiabetesmellitus
AT hofbauerlorenzc roleofosteogenicdickkopf1inboneremodelingandbonehealinginmicewithtypeidiabetesmellitus
AT raunermartina roleofosteogenicdickkopf1inboneremodelingandbonehealinginmicewithtypeidiabetesmellitus